This program is intended for registered nurses, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.
Upon completion of this activity, participants should be able to:
Joseph J. Eron Jr., MD
Herman and Louise Smith Distinguished Professor of Medicine
Chief, Division of Infectious Diseases
UNC-Chapel Hill School of Medicine
Chapel Hill, North Carolina
Joseph J. Eron, Jr., MD, has disclosed that he has received consultant/advisor/speaker fees from Gilead Sciences, Janssen, Merck, and ViiV Healthcare and funds for research support from Gilead Sciences, Janssen, and ViiV Healthcare.
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, FAANP, FAAN
Division of Advanced Nursing Practice
Rutgers School of Nursing
Newark, New Jersey
Gotham Medical Group
New York, New York
Jeffrey Kwong, DNP, MPH, FAANP, FAAN, has no relevant conflicts of interest to report.
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP, has disclosed that she has received consultant/advisor/speaker fees from Gilead Sciences, Janssen, Merck, Theratechnologies, and ViiV Healthcare.
Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN
Department of Infectious Diseases
School of Nursing and Medicine Johns Hopkins University
Department of Infectious Diseases
John G. Bartlett Specialty Practice
Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN, has no relevant conflicts of interest to report.
Jasjit Gill, BSPharm, PharmD
Pharmacist in Charge
Jasjit Gill, PharmD, RPh, has no relevant conflicts of interest to report.
Jessica L. Adams, PharmD, AAHIVE
Scientific Director, Infectious Diseases
Clinical Care Options
New York, United States
Jessica Adams, PharmD, has no relevant conflicts of interest to report.
Petra Cravens, PhD
Petra Cravens, PhD, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc, ELS
Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-9999-22-128-H02-P.
Type of Activity: Application
Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from May 10, 2022, through May 09, 2023:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
This program has been made available online.
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary ARV regimens.